Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Meiji Seika Pharma
Manufacturing
Japan awarded $115M to Arcturus JV to boost mRNA manufacturing
Arcturus’ local partner Meiji Seika Pharma expects a potential Japanese approval of Arcturus’ self-amplifying mRNA COVID-19 vaccine by year-end.
Angus Liu
Aug 14, 2023 11:58am
Takeda, Merck, SK Biopharm and more—Fierce Pharma Asia
Nov 12, 2021 9:20am
Meiji Seika to build $20.1M manufacturing plant in India
Nov 8, 2021 9:45am
Japan will buy 120 million shots from AZ starting early in 2021
Aug 7, 2020 9:30am
